Literature DB >> 20075302

Circadian locomotor rhythms are normal in Ts65Dn "Down syndrome" mice and unaffected by pentylenetetrazole.

Norman F Ruby1, Fabian Fernandez, Pei Zhang, Jessy Klima, H Craig Heller, Craig C Garner.   

Abstract

Ts65Dn mice are used extensively as a model for Down syndrome. Recent studies have reported conflicting evidence as to whether these mice express circadian rhythms. The authors therefore recorded locomotor activity patterns from these animals while they were housed under a standard light-dark cycle, constant darkness (DD), and constant light (LL). Contrary to expectations, Ts65Dn mice had more robust circadian rhythms with slightly shorter periods compared with their wild-type littermates. They also exhibited increased rhythm period and marked activity suppression when moved from DD to LL (i.e., Aschoff's rule). Administration of the GABA(A) antagonist pentylenetetrazole did not influence any of these circadian parameters. Thus, locomotor activity is under strict circadian control in Ts65Dn mice, suggesting that their cognitive deficits and sleep disturbances are not due to dysfunctional circadian timing as proposed previously.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20075302     DOI: 10.1177/0748730409356202

Source DB:  PubMed          Journal:  J Biol Rhythms        ISSN: 0748-7304            Impact factor:   3.182


  11 in total

1.  Reversible Suppression of Fear Memory Recall by Transient Circadian Arrhythmia.

Authors:  Athreya Steiger; Julia Farfan; Nathan Fisher; H Craig Heller; Fabian-Xosé Fernandez; Norman F Ruby
Journal:  Front Integr Neurosci       Date:  2022-05-27

2.  Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down's syndrome.

Authors:  D Colas; B Chuluun; D Warrier; M Blank; D Z Wetmore; P Buckmaster; C C Garner; H C Heller
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

Review 3.  Adaptive and pathological inhibition of neuroplasticity associated with circadian rhythms and sleep.

Authors:  H Craig Heller; Norman F Ruby; Asya Rolls; Megha Makam; Damien Colas
Journal:  Behav Neurosci       Date:  2014-06       Impact factor: 1.912

4.  Plant genetic archaeology: whole-genome sequencing reveals the pedigree of a classical trisomic line.

Authors:  Patrice A Salomé; Detlef Weigel
Journal:  G3 (Bethesda)       Date:  2014-12-18       Impact factor: 3.154

5.  Sleep-like behavior and 24-h rhythm disruption in the Tc1 mouse model of Down syndrome.

Authors:  I Heise; S P Fisher; G T Banks; S Wells; S N Peirson; R G Foster; P M Nolan
Journal:  Genes Brain Behav       Date:  2015-02-16       Impact factor: 3.449

6.  Young children with Down syndrome show normal development of circadian rhythms, but poor sleep efficiency: a cross-sectional study across the first 60 months of life.

Authors:  Fabian Fernandez; Casandra C Nyhuis; Payal Anand; Bianca I Demara; Norman F Ruby; Goffredina Spanò; Caron Clark; Jamie O Edgin
Journal:  Sleep Med       Date:  2017-02-10       Impact factor: 3.492

7.  Astrocyte deletion of Bmal1 alters daily locomotor activity and cognitive functions via GABA signalling.

Authors:  Olga Barca-Mayo; Meritxell Pons-Espinal; Philipp Follert; Andrea Armirotti; Luca Berdondini; Davide De Pietri Tonelli
Journal:  Nat Commun       Date:  2017-02-10       Impact factor: 14.919

Review 8.  The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome.

Authors:  Andrea Contestabile; Salvatore Magara; Laura Cancedda
Journal:  Front Cell Neurosci       Date:  2017-03-07       Impact factor: 5.505

9.  Suprachiasmatic lesions restore object recognition in down syndrome model mice.

Authors:  Bayarsaikhan Chuluun; Elsa Pittaras; Hyunseung Hong; Nathan Fisher; Damien Colas; Norman F Ruby; H Craig Heller
Journal:  Neurobiol Sleep Circadian Rhythms       Date:  2020-02-16

10.  Down syndrome and the molecular pathogenesis resulting from trisomy of human chromosome 21.

Authors:  Aarti Ruparelia; Frances Wiseman; Olivia Sheppard; Victor L J Tybulewicz; Elizabeth M C Fisher
Journal:  J Biomed Res       Date:  2010-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.